COVID-19 PandemicNCT05552989
Towards Better Preparedness for Future Catastrophes - Local Lessons-learned From COVID-19
An observational study of COVID-19 Pandemic and Emergencies, run by University Hospital Heidelberg at 1 site in Germany.
Trial summary
The research question of this study is: "what lessons have been learned from the civil-military cooperation in Heidelberg, Germany, during the COVID-19 pandemic, and what needs to be done to be better prepared for future disasters?" It is expected that the results of this research provide a deep expert insight into… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- COVID-19 Pandemic, Emergencies
- What is being tested?
- this is a non-interventional study
- How many people
- 12 participants
- Where
- 1 siteGermany
- Study dates
- 23 Sep 2022to 21 Jun 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: Key stakeholders of the local disaster relief community
Who may be able to join
- Age over 18 years
- Direct or indirect involvement in civil-military collaboration during the COVID-19 crisis
- Ability to provide consent
- Providing written informed consent to participate in the study
Who cannot join
- 1) Failure to provide written informed consent to participate in the study
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Towards Better Preparedness for Future Catastrophes - a Qualitative Mixed Methods Study of Lessons Learned From Civil-military Disaster Response in Heidelberg, Germany, During the COVID-19 Pandemic
The research question of this study is: "what lessons have been learned from the civil-military cooperation in Heidelberg, Germany, during the COVID-19 pandemic, and what needs to be done to be better prepared for future disasters?" It is expected that the results of this research provide a deep expert insight into COVID-19 disaster preparedness at the local level. Flanked by comparison with published experiences at the global level, these lessons-learned would contribute to strengthening local crisis resilience sustainably in the future.
Read the detailed description
Design, execution, analysis and publication of this study is conducted in compliance with the international quality criteria "STrengthening the Reporting of OBservational studies in Epidemiology (STROBE)" and "Standards for Reporting Qualitative Research (SRQR)".
This is a monocentric, qualitative, mixed-methods, non-interventional, non-randomized research project.
- Conditions
- COVID-19 Pandemic, Emergencies
- Being tested
- this is a non-interventional study
- Keywords
- COVID-19, disaster management, preparedness, lessons-learned, resilience
- Medical subject headings
- COVID-19, Emergencies
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
this is a non-interventional studyOther
this is a non-interventional study
| Study group | Role | What they receive |
|---|---|---|
| Key stakeholders of the local disaster relief community | Not described Receives: Other: this is a non-interventional study |
What is being measured
The primary outcome is the main question the study is designed to answer.
Civil-military disaster relief support to Heidelberg, Germany, during the COVID-19 crisis
Autoethnographic qualitative, empiric-observational analysis
Measured: Years 2020 to 2022
From civilian capability gaps towards societal resilience
Structured interview with key stakeholders of the local disaster relief community
Measured: One session of 2 hours (cross-sectional assessment at interview appointment)
From lessons-learned towards better future disaster preparedness
Structured interview with key stakeholders of the local disaster relief community
Measured: One session of 2 hours (cross-sectional assessment at interview appointment)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Sep 2022
- Study start23 Sep 2022
- Primary completion12 Apr 2023
- Study completion21 Jun 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for COVID-19 PandemicStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 12 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital Heidelberg
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Markus Ries, MD PhD MHSc FCP, University Hospital Heidelberg
- Investigators
- Markus Ries, MD, PhD, MHSc, FCP, Principal investigator, Heidelberg University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05552989
- Sponsor's protocol ID
- S-534/2022
- Status last verified
- Nov 2023
- First submitted
- 21 Sep 2022
- Last updated
- 29 Nov 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Schulze C, Welker A, Kuhn A, Schwertz R, Otto B, Moraldo L, Dentz U, Arends A, Welk E, Wendorff JJ, Koller H, Kuss D, Ries M. Public Health Leadership in a VUCA World Environment: Lessons Learned during the Regional Emergency Rollout of SARS-CoV-2 Vaccinations in Heidelberg, Germany, during the COVID-19 Pandemic. Vaccines (Basel). 2021 Aug 11;9(8):887. doi: 10.3390/vaccines9080887.
PubMed 34452012Ries M. Global key concepts of civil-military cooperation for disaster management in the COVID-19 pandemic-A qualitative phenomenological scoping review. Front Public Health. 2022 Sep 15;10:975667. doi: 10.3389/fpubh.2022.975667. eCollection 2022.
PubMed 36187698
Study at a glance
From the registry record, last updated by the sponsor on 29 Nov 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Towards Better Preparedness for Future Catastrophes - a Qualitative Mixed Methods Study of Lessons Learned From Civil-military Disaster Response in Heidelberg, Germany, During the COVID-19 Pandemic
- ClinicalTrials.gov ID
- NCT05552989
- Acronym / sponsor ID
- S-534/2022
- Conditions
- COVID-19 Pandemic, Emergencies
- Keywords
- COVID-19, disaster management, preparedness, lessons-learned, resilience
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 12 participants (actual)
- Lead sponsor
- University Hospital HeidelbergUniversity, hospital or other
- Study start
- 23 Sep 2022 (actual)
- Primary completion
- 12 Apr 2023 (actual)
- Study completion
- 21 Jun 2023 (actual)
- First posted
- 23 Sep 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The research question of this study is: "what lessons have been learned from the civil-military cooperation in Heidelberg, Germany, during the COVID-19 pandemic, and what needs to be done to be better prepared for future disasters?" It is expected that the results of this research provide a deep expert insight into COVID-19 disaster preparedness at the local level. Flanked by comparison with published experiences at the global level, these lessons-learned would contribute to strengthening local crisis resilience sustainably in the future.
Detailed description
Design, execution, analysis and publication of this study is conducted in compliance with the international quality criteria "STrengthening the Reporting of OBservational studies in Epidemiology (STROBE)" and "Standards for Reporting Qualitative Research (SRQR)".
This is a monocentric, qualitative, mixed-methods, non-interventional, non-randomized research project.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Key stakeholders of the local disaster relief community | – | Other: this is a non-interventional study |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Key stakeholders of the local disaster relief community
Key inclusion criteria (4 listed)
- Age over 18 years
- Direct or indirect involvement in civil-military collaboration during the COVID-19 crisis
- Ability to provide consent
- Providing written informed consent to participate in the study
Key exclusion criteria (1 listed)
- 1) Failure to provide written informed consent to participate in the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| this is a non-interventional studythis is a non-interventional study | Other | Key stakeholders of the local disaster relief community |
Primary outcome
Civil-military disaster relief support to Heidelberg, Germany, during the COVID-19 crisis
Time frame: Years 2020 to 2022
Autoethnographic qualitative, empiric-observational analysis
From civilian capability gaps towards societal resilience
Time frame: One session of 2 hours (cross-sectional assessment at interview appointment)
Structured interview with key stakeholders of the local disaster relief community
From lessons-learned towards better future disaster preparedness
Time frame: One session of 2 hours (cross-sectional assessment at interview appointment)
Structured interview with key stakeholders of the local disaster relief community
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Nov 2023.
- Background: PubMed 34452012Schulze C, Welker A, Kuhn A, Schwertz R, Otto B, Moraldo L, Dentz U, Arends A, Welk E, Wendorff JJ, Koller H, Kuss D, Ries M. Public Health Leadership in a VUCA World Environment: Lessons Learned during the Regional Emergency Rollout of SARS-CoV-2 Vaccinations in Heidelberg, Germany, during the COVID-19 Pandemic. Vaccines (Basel). 2021 Aug 11;9(8):887. doi: 10.3390/vaccines9080887.
- Background: PubMed 36187698Ries M. Global key concepts of civil-military cooperation for disaster management in the COVID-19 pandemic-A qualitative phenomenological scoping review. Front Public Health. 2022 Sep 15;10:975667. doi: 10.3389/fpubh.2022.975667. eCollection 2022.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: Undecided
Related trials for COVID-19 Pandemic
Active, not recruiting
Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use
Liver Diseases, Alcohol Use Disorder
Enrolling by invitationObservational study
Prescribing Trends and Associated Outcomes of Antiepileptic Drugs in US Nursing Homes Surrounding the COVID-19 Pandemic
Dementia
Active, not recruitingPhase 2
Improving Mental Health Among the LGBTQ+ Community
Anxiety, Depression
RecruitingObservational study
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
Breast Ductal Carcinoma In Situ, COVID-19 Infection
RecruitingObservational study
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
COVID-19 Infection, Melanoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Markus Ries, MD, PhD, MHSc, FCP principal investigator
Heidelberg University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of COVID-19 Pandemic and Emergencies, run by University Hospital Heidelberg at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Civil-military disaster relief support to Heidelberg, Germany, during the COVID-19 crisis (time frame: Years 2020 to 2022). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05552989, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2023.